These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17466416)

  • 21. Cardiovascular disease and statin drugs.
    Campbell AW
    Altern Ther Health Med; 2014; 20(5):8-9. PubMed ID: 25141364
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cardiovascular risk and possibilities of lowering it in patients with metabolic syndrome and type II diabetes mellitus. The role of fibrates].
    Konstantinov VO; Saĭfulina IaR
    Kardiologiia; 2006; 46(11):86-91. PubMed ID: 17183753
    [No Abstract]   [Full Text] [Related]  

  • 23. Statin therapy: when to think twice.
    Wahawisan J; Tovar JM; Granberry MC
    J Fam Pract; 2013 Dec; 62(12):726-32. PubMed ID: 24340334
    [No Abstract]   [Full Text] [Related]  

  • 24. Additional insights on how best to utilize statins.
    Feeman WE
    J Fam Pract; 2014 Mar; 63(3):128. PubMed ID: 24701605
    [No Abstract]   [Full Text] [Related]  

  • 25. Triglycerides and cardiovascular events in ACS: the need for combined lipid-altering therapies.
    Rosenson RS; Pitt B
    Nat Clin Pract Cardiovasc Med; 2009 Feb; 6(2):98-100. PubMed ID: 19079366
    [No Abstract]   [Full Text] [Related]  

  • 26. On the road to better dyslipidemia outcomes.
    Hughes S
    Nurse Pract; 2009 Feb; 34(2):14-21; quiz 22. PubMed ID: 19155874
    [No Abstract]   [Full Text] [Related]  

  • 27. Fibrates and future PPARalpha agonists in the treatment of cardiovascular disease.
    Staels B; Maes M; Zambon A
    Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):542-53. PubMed ID: 18628776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative risk of severe hypoglycemia among concomitant users of thiazolidinedione antidiabetic agents and antihyperlipidemics.
    Leonard CE; Han X; Bilker WB; Flory JH; Brensinger CM; Flockhart DA; Gagne JJ; Cardillo S; Hennessy S
    Diabetes Res Clin Pract; 2016 May; 115():60-7. PubMed ID: 27242124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Options for the treatment of hyperlipidemia in Type 2 diabetes mellitus and hypothyroidism: lowering the cardiovascular risk.
    Duntas L; Kolovou G
    Future Cardiol; 2011 Mar; 7(2):137-44. PubMed ID: 21453018
    [No Abstract]   [Full Text] [Related]  

  • 30. All at sea: new lipid-lowering drug trials continue to disappoint.
    Wierzbicki AS
    Int J Clin Pract; 2013 Jul; 67(7):595-8. PubMed ID: 23758438
    [No Abstract]   [Full Text] [Related]  

  • 31. Statins in liver disease: not only prevention of cardiovascular events.
    Magan-Fernandez A; Rizzo M; Montalto G; Marchesini G
    Expert Rev Gastroenterol Hepatol; 2018 Aug; 12(8):743-744. PubMed ID: 29768950
    [No Abstract]   [Full Text] [Related]  

  • 32. Hypertriglyceridemia and cardiovascular disease management.
    Codario RA
    J Am Acad Nurse Pract; 2007; 19(12 Suppl 2):7-10, 13-4. PubMed ID: 18510282
    [No Abstract]   [Full Text] [Related]  

  • 33. [On behalf and the extent of evidence].
    Ruiz J
    Rev Med Suisse; 2010 Jun; 6(252):1171-2. PubMed ID: 20614750
    [No Abstract]   [Full Text] [Related]  

  • 34. Management of dyslipidemia in patients with complicated metabolic syndrome.
    Davidson MH
    Am J Cardiol; 2005 Aug; 96(4A):22E-25E. PubMed ID: 16098839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drugs for hypertriglyceridemia.
    Med Lett Drugs Ther; 2013 Mar; 55(1411):17-9. PubMed ID: 23467119
    [No Abstract]   [Full Text] [Related]  

  • 36. Trial clouds use of niacin with a statin.
    Harv Heart Lett; 2011 Aug; 21(12):2. PubMed ID: 21991606
    [No Abstract]   [Full Text] [Related]  

  • 37. After FIELD: should fibrates be used to prevent cardiovascular disease in diabetes?
    Colhoun H
    Lancet; 2005 Nov; 366(9500):1829-31. PubMed ID: 16310536
    [No Abstract]   [Full Text] [Related]  

  • 38. Drug therapy of diabetic dyslipidemia: do the statins suffice?
    Mooradian AD
    Am J Ther; 2015; 22(1):87-8. PubMed ID: 23728161
    [No Abstract]   [Full Text] [Related]  

  • 39. [The utility of antilipemic agents in the area of secondary prevention].
    Weizet A
    Pharm Unserer Zeit; 2006; 35(2):172. PubMed ID: 16583572
    [No Abstract]   [Full Text] [Related]  

  • 40. Fibrates consistently lower risk of cardiovascular events across high-risk groups.
    Aalbers J
    Cardiovasc J Afr; 2010; 21(3):174. PubMed ID: 20532463
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.